Santarus Inc (NASDAQ:SNTS)

22.28
Data as of May 22
 -0.02 / -0.09%
Today’s Change
4.82
Today|||52-Week Range
24.00
+102.91%
Year-to-Date
Data on Merck KGaA's L-BLP25 - Analyst Blog
May 22 / Zacks.com
Synergy Pharma Posts Wider Loss - Analyst Blog
May 15 / Zacks.com
Data on UCB's Neupro - Analyst Blog
May 22 / Zacks.com
Merck KGaA Posts Higher Y/Y Earnings - Analyst Blog
May 15 / Zacks.com
XenoPort Resumes Horizant Supply - Analyst Blog
May 22 / Zacks.com
Dr. Reddy's Earnings Increase Y/Y - Analyst Blog
May 15 / Zacks.com
Sanofi/REGN's Dupilumab Data Published - Analyst Blog
May 22 / Zacks.com
Forest-Trevena Ink Deal - Analyst Blog
May 14 / Zacks.com
FDA Designation for Synageva Candidate - Analyst Blog
May 22 / Zacks.com
Jazz Pharma Posts Higher Y/Y Earnings - Analyst Blog
May 14 / Zacks.com
Swiss Issue for AMAG/Takeda's Rienso - Analyst Blog
May 22 / Zacks.com
Salix Beats on Earnings - Analyst Blog
May 14 / Zacks.com
Additional Patent for Acorda's Ampyra - Analyst Blog
May 22 / Zacks.com
Narrower-than-Expected Loss at Supernus - Analyst Blog
May 14 / Zacks.com
Generic Launches at Mylan Continue - Analyst Blog
May 22 / Zacks.com
Teva - Alexza Sign Deal for Adasuve - Analyst Blog
May 13 / Zacks.com
Bull of the Day: Santarus (SNTS) - Bull of the Day
May 22 / Zacks.com
Wider-Than-Expected Loss at Anacor - Analyst Blog
May 13 / Zacks.com
AbbVie Extends Galapagos Deal - Analyst Blog
May 22 / Zacks.com
Pernix Reports Loss in 1Q - Analyst Blog
May 13 / Zacks.com
Positive Data on Novo Nordisk's N9-GP - Analyst Blog
May 21 / Zacks.com
Lilly Scraps Oncology Candidate - Analyst Blog
May 13 / Zacks.com
Actavis to Buy Warner Chilcott - Analyst Blog
May 21 / Zacks.com
Narrower-than-Expected Loss at MannKind - Analyst Blog
May 13 / Zacks.com
JNJ's Simponi Label Expanded - Analyst Blog
May 21 / Zacks.com
Simcere Beats 1Q Earnings & Revenue Estimate - Analyst Blog
May 10 / Zacks.com
FDA Accepts Actavis NDA - Analyst Blog
May 20 / Zacks.com
Pacira Reports Wider Loss - Analyst Blog
May 10 / Zacks.com
Requiem for the Bears
May 17 / TheStreet.com
Positive Data on Celgene's Apremilast - Analyst Blog
May 09 / Zacks.com
Digging for New Buys
May 17 / TheStreet.com
Wider-than-Expected Loss at Avanir - Analyst Blog
May 09 / Zacks.com
Good News for Novartis' Ilaris - Analyst Blog
May 15 / Zacks.com
Narrower-Than-Expected Loss at Rigel Pharma - Analyst Blog
May 09 / Zacks.com
Pediatric Approval for MDCO/BMY's Recothrom - Analyst Blog
May 15 / Zacks.com
 

To view my watchlist

Not a member yet?

Sign up now for a free account

jobs by SimplyHired

Search for jobs

Search All Jobs from Across the Web

Market indexes are shown in real time, except for the DJIA, which is delayed by two minutes. All times are ET. Disclaimer LIBOR Warning: Neither BBA Enterprises Limited, nor the BBA LIBOR Contributor Banks, nor Reuters, can be held liable for any irregularity or inaccuracy of BBA LIBOR. Disclaimer. Morningstar: © 2013 Morningstar, Inc. All Rights Reserved. Disclaimer The Dow Jones IndexesSM are proprietary to and distributed by Dow Jones & Company, Inc. and have been licensed for use. All content of the Dow Jones IndexesSM © 2013 is proprietary to Dow Jones & Company, Inc. Chicago Mercantile Association. The market data is the property of Chicago Mercantile Exchange Inc. and its licensors. All rights reserved. FactSet Research Systems Inc. 2013. All rights reserved. Most stock quote data provided by BATS.